Vaxxinity Issues Shareholder Letter
Vaxxinity, Inc. (VAXX)
Company Research
Source: GlobeNewswire
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced issued a letter to shareholders from its Co-founder and Executive Chairman, Lou Reese and Chief Executive Officer, Mei Mei Hu. To Shareholders of Vaxxinity, Inc.: Earlier today, we announced that we are delisting and deregistering our shares. A few weeks from now, we will no longer be publicly traded on the NASDAQ exchange. It is important to share why we made this decision to “go dark” and why we believe it is in the best interests of the company and our shareholders over the longer-term. Being a public company is very expensive and incredibly time-consuming. Choosing to go public is a path many pursue primarily to obtain access to greater institutional pools of capital. Since the company’s IPO in November 2021, the capital markets have been uniquely and historic
Show less
Read more
Impact Snapshot
Event Time:
VAXX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VAXX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VAXX alerts
High impacting Vaxxinity, Inc. news events
Weekly update
A roundup of the hottest topics
VAXX
News
- Vaxxinity Issues Shareholder Letter [Yahoo! Finance]Yahoo! Finance
- Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock [Yahoo! Finance]Yahoo! Finance
- Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common StockGlobeNewswire
- Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual MeetingGlobeNewswire
VAXX
Earnings
- 3/27/24 - Beat
VAXX
Sec Filings
- 5/3/24 - Form EFFECT
- 4/30/24 - Form S-8
- 4/30/24 - Form S-8
- VAXX's page on the SEC website